Join
Live feed
·
PRReleasevia Quantisnow
TC BioPharm (Holdings) plc logo

TC BioPharm Announces Complete Response in Minimal Residual Disease (MRD) Patient

ByQuantisnow·Wall Street's wire, on your screen.
TCBP· TC BioPharm (Holdings) plc
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track TCBP (TC BioPharm (Holdings) plc) and more on Quantisnow.